Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Key Driver in Gastric Cancer Progression Uncovered
August 2025
A new review highlights the growing role of fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
Read more
11 Aug 2025
Key Driver in Gastric Cancer Progression Uncovered
A new review highlights the growing role of fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
8 Aug 2025
Artificial Intelligence Cracks Tumour’s Hidden Code
A new AI model, AAnet, reveals that tumours are made up of a continuum of functional cell states. It identifies GLUT3 as a key driver of metastasis.
7 Aug 2025
Chemoradiation Outcomes Comparable Across Age Groups in Oesophageal Cancer
A new study from Ireland shows that neoadjuvant chemoradiation is safe and effective in older adults with oesophageal cancer, with no survival disadvantage versus younger patients.
5 Aug 2025
HANCOCK Dataset Gives Hope for Precision Medicine in Head and Neck Cancer
Researchers in Germany have developed HANCOCK, a comprehensive dataset of head and neck cancer cases, to support biomarker discovery and precision oncology.
31 Jul 2025
Modifiable Risk Factors Behind Majority of Liver Cancers
At least 60% of liver cancer diagnoses are linked to modifiable risk factors and could be prevented through global interventions
24 Jul 2025
Heart Biomarkers Linked to Higher Cancer Risk
Higher levels of two cardiac biomarkers at baseline are associated with an increased risk of future cancer…
24 Jul 2025
No Survival Difference in Patients with Both Lung Cancer and Rheumatoid Arthritis
A new study has found that patients with metastatic non–small cell lung cancer and pre-existing rheumatoid arthritis have similar overall survival to those without RA when treated with immune checkpoint inhibitors…
23 Jul 2025
Hybrid Tumour-Immune Cells Found in Blood of Patients with Breast Cancer
Scientists have identified a rare and previously overlooked type of circulating tumour cell (CTC) in patients with metastatic breast cancer…
Loading posts...
1
2
3
…
52
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View